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Abstract: Although direct determination of
the lactase activity of the small intestinal
mucosa is considered a “gold standard” for
the diagnosis of hypolactasia leading to lactose
malabsorption, less invasive and simpler
indirect techniques like the “plasma glucose
response test” and “breath hydrogen test” are
preferred in daily practice to diagnose the
disorder. The aim of this study was to
compare the different indirect diagnostic
methods for lactose malabsorption. The
following tests were performed in 54 adults:
plasma glucose response test, breath
hydrogen test and urine galactose/creatinine
ratio. The diagnostic variables were as
follows: increased plasma glucose ≤ 20 mg/dl;
increased exhalation of breath hydrogen ≥ 20
ppm, and urinary galactose/creatinine ≤ 0.1
mg/mg 60 min after 50 g oral lactose loading.
Using the gold standard of two diagnostic
variables (plasma glucose response test and
breath hydrogen test) being positive, lactose
malabsorption rate was found to be 85%.
Positive predictive values of the plasma
glucose response test and breath hydrogen
test were 93.8% and 95.8%, respectively.
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Introduction
Disaccharide lactose is split in the small bowel by
enzyme lactase (a β-galactosidase) into equal molecular
amounts of glucose and galactose. The activity of lactase
is high at birth. In the majority of the world’s population
it decreases after infancy (1). The primary lactase
deficiency rate was reported to be 71% among the adult
population in Turkey (2).
Individuals with hypolactasia malabsorb ingested
lactose, the unhydrolyzed lactose, which by osmosis
draws water into the small intestine, passes to the colon
and is fermented by colonic bacteria into volatile fatty
acids, hydrogen, methane and carbon dioxide. Hydrogen
gas (H2) is absorbed in part and excreted in the breath of
individuals with lactose malabsorption (3). This results in
considerable suffering from abdominal pain, bloating,
flatus and diarrhea (4).
Lactose malabsorption can not be determined from a
patient’s clinical history, because many patients do not

The discordance rate of the tests was 9.2%.
We modified a qualitative galactose spot test
to determine urinary galactose quantitatively,
and used the galactose/creatinine ratio for the
indirect detection of lactose malabsorption.
The sensitivity, positive predictivity and
negative predictivity of the urinary
galactose/creatinine ratio at 60 min were
determined to be 93.4%, 93.4% and 37.5%,
respectively.
In conclusion, we suggest the use of the
positivity of any two (instead of the former
use of only one) of these three indirect
methods in accordance with the suitability of
the technical equipment of a laboratory, as a
“gold standard” for diagnosing lactose
malabsorption. Being noninvasive, safe and
accurate, we propose the use of a combination
of urinary galactose/creatinine ratio and
breath hydrogen test, where available, as a
convenient protocol for the diagnosis of
lactose malabsorption.
Key Words: Lactose malabsorption, urinary
galactose, breath hydrogen test, lactose
tolerance test

recognize the symptoms and some remain asymptomatic
(5). Lactose malabsorption is diagnosed by a variety of
methods including plasma glucose response test (the
classical lactose tolerance test) based on serial blood
glucose determination (6), the breath hydrogen test (7)
and the measurement of lactase from a small bowel
biopsy (8).
The direct lactase assay and the determination of the
lactase to sucrase ratio from jejunal biopsy is the most
reliable method, but it understandably cannot be the
method of choice for outpatient clinics (9,10).
The most commonly used indirect method is serial
blood glucose determinations after an oral lactose load.
This test is very simple to perform and standardize, and
is minimally invasive. However, its sensitivity and
specificity are questionnable owing to variations in, for
example, gastric emptying and the glucose metabolism
(11). The test is of little use in patients with diabetes
(12).
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The breath hydrogen test is based on the rise in
exhaled breath hydrogen that is formed from unabsorbed
lactose in the colon by appropriate bacteria. Serial
sampling at intervals of 15 min to 1 h for 2 to 4 h is
needed during the test. Although it is considered the most
reliable, non-invasive and economical technique by some
authors (7,13), Arola et al. (10) determined a lower
sensitivity (69%) for the test in comparison with other
methods (81-94%).
The urinary galactose determination test is another
approach suggested for the diagnosis of lactose
malabsorption. The theory of the test relies upon the
determination of the excreted amount of urinary
galactose that passes into portal circulation following its
absorption in the gastrointestinal canal and, that was able
to break away from hepatic clearance despite its presence
at low plasma concentrations. A diminution in the
galactose excretion rate is expected in cases with lactose
malabsorption (14). The measurement of urinary
galactose using commercial test strips has been
suggested, but those test strips, which use galactose
oxidase, are no longer available (15). Grant et al. (16)
reported
that
the
measurement
of
the
galactose/creatinine ratio in the first 3 h urine samples
after drinking a lactose load of 50 g discriminates
between healthy people and individuals with lactose
malabsorption.
Buttery et al. (17) developed a “visual screening”
method for urine samples after 1 h for the determination
of galactose concentration used to diagnose lactose
maldigestion. In the study, the patients were given 300
mg/kg of body-weight ethanol for the inhibition of
galactose to glucose conversion in the liver as well as a 50
g lactose load; the sensitivity of the method was
established to be 93%. On the other hand, as a noninvasive method, the diagnostic value of urinary galactose
determination is thought to have been insufficiently
assessed by some authors (18).
We compared the usefulness of indirect diagnostic
tests concerning the evaluation of lactose malabsorption
(e.g., plasma glucose response test, breath H2 test and
urinary galactose/creatinine ratio) to elucidate the
etiology of disorders such as recurrent abdominal pain
in children, irritable bowel syndrome and chronic
diarrhea.
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Materials and Methods
Fifty-four adult patients (age range: 20-59 years)
who attended the Gastroenterology Department of GATA
Medical Faculty and were referred to our laboratory for
the assessment of lactose intolerance were recruited for
this study. The members of the study group were advised
to abstain from foodstuffs that delayed intestinal
passage, such as leguminous food as well as cereal
containing bran and fiber, and were encouraged to eat
meat or rice at dinner the day before the investigation.
Patients who had been treated with an antibiotic drug
were not included in the study at least before 15 days
following completion of the medication. Patients with
active diarrhea during or shortly prior to the test were
also excluded.
The below mentioned test protocol (Fig. 1) was
practised after an overnight fast, during which the
patients were allowed to drink some water. The patients
were not allowed to exercise, smoke, eat or drink during
the test period.
In brief, after an overnight fast (zero min, basal
samples), a urinary sample was taken and a venous blood
sample was drawn into vacuum tubes containing
EDTA/flouride as well as obtaining end-expiratory breath
H2 samples immediately before the lactose challenge.
Following the administration of 50 g of lactose orally
within 5 min dissolved in 400 ml water, blood (30 min
and 60 min) and urine (60 min) samples were obtained.
End-expiratory breath samples of 20 ml were taken at
regular intervals of 30, 60, 90, 120 and 180 min after
the lactose load.
The glucose levels of the plasma samples were
determined on a Dax-48 autoanalyzer (Bayer, Germany)
by using a commercially available glucose oxidaseperoxidase enzymmatic method at the date of sampling,
after obtaining the plasma samples by centrifugation at
2,000 rpm for 10 min. Delta (▲
▲) plasma glucose levels
were calculated by subtracting the baseline glucose level
from the peak glucose level after the lactose challenge.
Breath samples were taken regularly in gas sampler
bags as end-expiratory samples and they were analyzed
immediately by a hydrogen analyzer (Quintron CM2
Microlyzer, USA). The analyzer was calibrated daily with
a 100 ppm H2 standard and was linear between the 0 and
200 ppm H2 level. Delta (▲
▲) breath hydrogen was
defined as the highest breath H2 concentration minus the
baseline (fasting) H2 value.
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Urinary creatinine levels were determined on a Dax48 autoanalyzer (Bayer, Germany) by using the kinetic
Jaffe method. Urinary galactose levels were determined
by improving the visual spot test of Buttery et al. (17)
into a quantitative method by our group.
The chemical principle to determine urinary galactose
was as follows:
galactose dehydrogenase
+

galactose + NAD

➙

galactano-lactone + NADH

NADH + PMS

➙

NAD + PMS.H

PMS.H + INT

➙

PMS + reduced INT (red formazan)

Following the lactose challenge, a peak glucose rise of
≤ 20 mg/dl, or an exhalated H2 increment of ≥ 20 ppm
(11), or a galactose/creatinine ratio of ≤ 0.1 mg/mg (16)
in comparison with baseline levels were all accepted as
predictors of lactose malabsorption.
Statistical Analysis
Statistical analyses were carried out by using SPSS
and EXCEL for Windows. Relationships between the
variables were detected by Pearson’s correlation test; a pvalue less than 0.05 was considered statistically
significant.

The procedure can briefly be explained as follows:
To determine the amount of galactose in urine
samples, to 50 µl of urine sample (test) or standard (18
mg/dl galactose) in a cuvette were added 50 µl pooled
plasma, 0.5 ml of buffer (phosphate buffer 0.2 mol/l, pH
7.5), 50 µl of color reagent (containing 80 mg of p-iodo
nitrotetrazolium violet, 200 mg of NAD and 5 mg of
phenazine methosulfate in 20 ml of water), and 0.075 U
of galactose dehydrogenase, followed by mixing. Distilled
water rather than was used for blanking. After
incubation for 15 min at room temperature in a dark
chamber, test and standard absorbances were measured
against the blank at 500 nm with a spectrophotometer.
The results were evaluated according to prepared
calibration graphics.
A corrected galactose concentration was established
by subtracting the baseline galactose value from galactose
concentration at 60 min., and this figure was used to
calculate the urinary galactose/creatinine ratio; the results
of the corrected galactose concentration were expressed
per creatinine concentration (mg/mg).

urine sample

Results
The results of different analyses performed on the 54
adult patients with probable lactose intolerance are
depicted in Figure 2. Positivity rates for the plasma
glucose response test, breath H2 test and urinary
galactose/creatinine ratio were 90%, 89% and 85%,
respectively.
Taking the plasma glucose response test and the
breath H2 test into consideration, both of the tests were
positive in 46 patients while only one alone was positive
in five patients and no positivity was achieved in three
patients (Table).
When the positivity of the plasma glucose response
test plus the breath H2 test was accepted for the twopositive criterion as suggested by Peuhkuri et al. (19),
lactose malabsorption frequency was established to be
(46/54) 85%. The positive predictive values of the tests
were calculated to be 93.8% and 95.8%, respectively
(Table).
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Figure 1. Lactose loading test protocol.
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Figure 2. The distribution spectra of lactose tolerance tests.
(a) Plasma glucose response test

(b) Breath H2 test

(c) Urinary galactose/creatinine ratio

Table Results of different tests in the study group.

Urinary galactose/creatinine ratio:
≤ 0.1 mg /mg

43

Urinary galactose/creatinine ratio:
≥ 0.1 mg /mg

3

No correlation was established between the results of the
plasma glucose response test and those of the breath H2 test
(Fig. 3); however, a moderate correlation was found
between the plasma glucose response test and the urinary
galactose/creatinine ratio (r = 0.594, p < 0.05) (Fig. 4).
Scanning the absorption spectrum of the final color
reached at the end of the quantitative urinary galactose
determination test, a peak maximum of around 500 nm
was obtained (Fig. 5).
The method was found to be linear between galactose
concentrations of 0 and 54 mg/dl; thus, allowing the
determination of urinary galactose quantity following a
lactose challenge (Fig. 6).
Taking the plasma glucose response test plus the
breath H2 test as the “diagnostic standard”, two positive
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Breath H2 test: (-)
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The correlation between the plasma glucose response test
and the breath H2 test.
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The absorption spectrum of the final color obtained during
urinary galactose level determination. A peak maximum
around 500 nm wavelength was determined.

results, two negative results and a positive plus a negative
result of any combination were evaluated as lactose
malabsorber (LM), normal lactose absorber (LA) and
equivocal result, respectively. Regarding this evaluation,
the sensitivity of the urinary galactose/creatinine ratio
test was found to be 93.4%, and a distribution plotting
of the results is depicted in Figure. 7. The positive
predictive value was established to be 93.4% with the
negative predictive value being 37.5% (Table).

Figure 7.

Lactose
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Absorbe

Uncertain
Group
Grou

Results of urinary galactose/creatinine ratio of the study
group.
(LA: lactose
malabsorption)

absoption

[normal];
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lactose

Discussion
In the present study, the results of a classical lactose
tolerance test (plasma glucose response test) and two
non-invasive, indirect tests (breath H2 and urinary
galactose/creatinine ratio) used in the diagnosis of lactose
malabsorption are compared with each other.
Despite the determination of lactase activity from
jejunal biopsy being the most reliable method, with it
being used as a “gold standard” for comparing indirect
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diagnostic methods of lactose malabsorption, this step
was excluded from the study owing to the difficulty in
using it in all the patients. On the other hand, lactase
activity from the jejunal biopsy was speculated to not be
a “gold standard” owing to the uneven dissemination of
lactase activity throughout the small intestine mucosal
structure (18,20). Thus, we preferred the “two positive
parameter” criterion of two recent studies (19,21) as a
“gold standard” for the diagnosis of lactose
malabsorption rather than the direct determination of
lactase activity.
By using this criterion, we found the lactose
malabsorption rate to be ≈ 85% for adult individuals
among the study group. This finding was consistent or
even a little higher than the result established by Flatz et
al. (2), who found the lactase deficiency rate to be 71%
in 471 Turkish soldiers by utilizing the breath H2 test.
Although the 85% might cover some patients with
secondary malabsorption or generalized malabsorption
disorders (22), in our opinion, this figure reflects the
predominant lactose malabsorption due to primary adult
lactase deficiency with great probability. These findings
suggest that lactase malabsorption is a gastrointestinal
disorder that is common in the adult Turkish population,
and thus predicts necessity of using the lactose challenge
test in the differential diagnosis of disorders with
comparable signs and symptoms like irritable bowel
syndrome and chronic diarrhea.
There was a discordance of 9.2% between the plasma
glucose response test and the breath H2 test results
within the study group; i.e. the result of any kind of test
was positive while the other kind being negative for
lactose malabsorption. The same disordance rate was
reported to be 14.5% by Van Krughen et al. (23) in a
series of 40 patients, while Hermans et al. (20) expressed
the same rate as 42% in their series of 309 cases. On the
other hand, no correlation was established between the
results of these parameters (Fig. 3). The discordance may
be explained by the fact that different parameters
regarding lactose malabsorption are measured by each
test. When the plasma glucose increment rate is directly
proportional to the amount of lactose being hydrolyzed
by the lactase enzyme, the rise in the level of breath H2 is
proportional to the quantity of unhydrolyzed lactose.
Nevertheless, some factors influencing parameters may
contribute to each result; e.g., plasma glucose level is
affected by an alteration in hormone concentration and by
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a delay in stomach evacuation; factors like H2 generation
capacity (2-20% of patients may be colonized with
bacteria incapable of producing hydrogen), small bowel
passage time, bacteria overgrowth within the small bowel
and H2 consumption by the colon may all manipulate
breath H2 levels (22). Although variations in renal
excretion function and/or hepatic galactose to glucose
conversion capacity may theoretically be expected to lead
to alterations in the urinary galactose excretion rate, we
observed a significant corelation between the results of
the urinary galactose/creatinine ratio and plasma glucose
response test (Fig. 4).
When we used the positivity of the both tests (plasma
glucose response and breath H2) as an indicator of lactose
malabsorption, we determined that the positive predictive
values of the plasma glucose and breath H2 tests were
close to each other (93.8 and 95.8, respectively).
Negative predictive values were not taken into
consideration due to insufficient data.
The urinary spot test for qualitative galactose
determination of Buttery et al. (17) was improved into a
quantitative method by us. The color of formazan, which
is the final product during the test procedure, was
measured at the visible area of a spectrophotometer
owing to its maximum absorbance at 500 nm. This
method allows the quantification of urinary galactose
concentration with the use of less expensive optic devices
like an ordinary spectrophotometer in comparison with
the determination of urinary galactose at ultraviolet
wavelength (16) by the use of a sophisticated one.
Although ethanol administration along with lactose
load had been suggested for the inhibition of hepatic
galactose to glucose conversion in some lactose challenge
methodologies (9,17), ethanol has been considered to be
useless for this purpose (16, 24). Thereupon, we utilized
the lactose challenge protocol without ethanol
administration.
When the galactose/creatinine ratio of ≤ 0.1 mg/mg
in spot urine sample 1 h following the lactose load was
considered a predictor of lactose malabsorption, as
proposed by Grant et al. (16), 43/46 patients (diagnostic
sensitivity = 93.4%) were diagnosed to be lactose
malabsorbers according to the results of two positive
parameters. Although the number of participants with
normal lactose absorption was insufficient (n = 3), the
urinary galactose/creatinine ratio was found to be
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negative in these individuals. The sensitivity of the test
was slightly lower in comparison with the results of Grant
et al. (16), suggesting the 3 h urinary galactose/creatinine
ratio as discriminating (sensitivity = 100%) patients with
lactose malabsorption diagnosed with the breath H2 test
from normal individuals. This discrepancy may be related
to diagnostic indicators of lactose malabsorption,
sampling intervals or methodological differences.
The positive predictive value of 93.4% showed the
possible use of a urinary galactose/creatinine ratio of ≤
0.1 mg/mg as an indicator of lactose malabsorption. This
value was 94% in a study protocol (10) during which a
40 min urinary galactose concentration was considered to
be a diagnostic criterion following a lactose challenge with
ethanol load. As the negative predictive value was low,
negative values cannot be used for the exclusion of lactose
malabsorption.
The results of the three available indirect diagnostic
tests for the prediction of lactose malabsorption were
concordant amongst > 90% of the participant individuals
and the positive predictive values were > 90%. These
results provide a larger scale of test selection in
compliance with the technical efficiency of a laboratory
for the diagnosis of lactose malabsorption. The need for

special equipment to conduct a breath H2 test and the
partially invasive nature of plasma glucose determination
make the urinary galactose/creatinine ratio an attractive
alternative for diagnosing lactose malabsorption
disorders.
In conclusion, due to the difficulty of performing
direct lactase activity determination in all patients, we
suggest the use of two-positive parameter criterion to
improve the diagnostic accuracy of indirect tests
concerning lactose malabsorption, which is a frequently
faced disorder in Turkey. Being non-invasive approaches,
the breath H2 test and the urinary galactose/creatinine
ratio protocol carried out following a 50 g lactose load
without ethanol administration seems to be a convenient
protocol for that purpose.
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